Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sina Nikayin

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
CNS Drugs|September 7, 2021
Evaluating the Role of Ketamine/Esketamine in the Management of Major Depressive Disorder with Suicide RiskSina Nikayin, Gerard Sanacora
JAMA Psychiatry|July 5, 2023
The Intricate Interaction Between Expectations and Therapeutic Outcomes of Psychedelic AgentsLuana Colloca, Sina Nikayin, Gerard Sanacora
The Journal of ECT|February 27, 2022
Catatonia After COVID-19: A Case SeriesSina Nikayin, Jessica Chaffkin, Robert B Ostroff
Journal of the Neurological Sciences|January 2, 2022
Advanced training in interventional psychiatrySina Nikayin, Joseph J Taylor, Robert B Ostroff
Journal of Affective Disorders|April 4, 2025
Does BMI matter when treating depression with esketamine? A retrospective analysis of real-world dataMina Ansari, Taeho Greg Rhee, Mia C Santucci, et al.
The New England Journal of Medicine|May 29, 2024
Depression - Advanced Treatments for Treatment-Resistant DepressionMario Cristancho, Maurizio Fava, Julie Ingelfinger, et al.
Expert Opinion on Drug Safety|April 13, 2022
Long-term safety of ketamine and esketamine in treatment of depressionSina Nikayin, Eva Murphy, John H Krystal, et al.
Annals of the American Thoracic Society|March 30, 2017
Validity of the Posttraumatic Stress Symptoms-14 Instrument in Acute Respiratory Failure SurvivorsAnn M Parker, Sina Nikayin, O Joseph Bienvenu, et al.
Psychopharmacology|September 20, 2025
Lamotrigine is not associated with differential clinical outcomes in a real-world sample of patients with unipolar depression receiving ketamine or esketamineMia C Santucci, Rachel B Katz, Brian Pittman, et al.
General Hospital Psychiatry|July 11, 2024
Blood pressure changes during ketamine infusion for the treatment of depressionMina Ansari, Brian Pittman, Daniel S Tylee, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
CNS Drugs|September 7, 2021
Evaluating the Role of Ketamine/Esketamine in the Management of Major Depressive Disorder with Suicide RiskSina Nikayin, Gerard Sanacora
JAMA Psychiatry|July 5, 2023
The Intricate Interaction Between Expectations and Therapeutic Outcomes of Psychedelic AgentsLuana Colloca, Sina Nikayin, Gerard Sanacora
The Journal of ECT|February 27, 2022
Catatonia After COVID-19: A Case SeriesSina Nikayin, Jessica Chaffkin, Robert B Ostroff
Journal of the Neurological Sciences|January 2, 2022
Advanced training in interventional psychiatrySina Nikayin, Joseph J Taylor, Robert B Ostroff
Journal of Affective Disorders|April 4, 2025
Does BMI matter when treating depression with esketamine? A retrospective analysis of real-world dataMina Ansari, Taeho Greg Rhee, Mia C Santucci, et al.
The New England Journal of Medicine|May 29, 2024
Depression - Advanced Treatments for Treatment-Resistant DepressionMario Cristancho, Maurizio Fava, Julie Ingelfinger, et al.
Expert Opinion on Drug Safety|April 13, 2022
Long-term safety of ketamine and esketamine in treatment of depressionSina Nikayin, Eva Murphy, John H Krystal, et al.
Annals of the American Thoracic Society|March 30, 2017
Validity of the Posttraumatic Stress Symptoms-14 Instrument in Acute Respiratory Failure SurvivorsAnn M Parker, Sina Nikayin, O Joseph Bienvenu, et al.
Psychopharmacology|September 20, 2025
Lamotrigine is not associated with differential clinical outcomes in a real-world sample of patients with unipolar depression receiving ketamine or esketamineMia C Santucci, Rachel B Katz, Brian Pittman, et al.
General Hospital Psychiatry|July 11, 2024
Blood pressure changes during ketamine infusion for the treatment of depressionMina Ansari, Brian Pittman, Daniel S Tylee, et al.
Pageof 3